Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $156.22 -0.22%
EPS Growth %: -12.4%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: -12.4%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Investing.com’s stocks of the week
- UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
